期刊
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
卷 22, 期 2, 页码 191-198出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/IGC.0b013e318236a2ec
关键词
Retinoid; Ovarian cancer
Ovarian cancer is the deadliest of all gynecologic malignancies. The search for novel treatment modalities to augment traditional chemotherapy and improve quality of life is ongoing. Retinoids, a class of compounds composed of vitamin A, its natural derivatives, and synthetic analogs, have been studied extensively in both the prevention and treatment of gynecologic malignancies. In this article, we reviewed preclinical studies and clinical trials conducted using retinoids in ovarian cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据